INTEST CORP INTT
InTest Corporation, headquartered in Mount Laurel, New Jersey, was incorporated in New Jersey in 1981 and reincorporated in Delaware in April 1997. We completed our initial public offering in June 1997 and currently trade on the NYSE American stock exchange under the symbol "INTT." The consolidated entity is comprised of InTest Corporation and our wholly owned subsidiaries which comprise our six businesses: Electro Mechanical Semiconductor ("EMS"), Acculogic, Alfamation™, InTest Thermal Solutions ("ITS"), Ambrell® and Videology®.
We are a global supplier of innovative test and process technology solutions for use in manufacturing and testing across a wide range of markets including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security and Other. We operate our business worldwide, sell our products both domestically and internationally and manufacture our products in the U.S., Canada, Italy and began limited manufacturing in Malaysia in the fourth quarter of 2025. Marketing and support activities are conducted worldwide from our facilities in the U.S., Canada, Italy, Germany, Singapore, Malaysia, and the U.K. We have three operating segments which are also our reportable segments and reporting units: Electronic Test, Environmental Technologies and Process Technologies.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- Foreign
- U.S. Federal
| Region | FY2025 | FY2024 |
|---|---|---|
| Foreign | $64.7M | $80.9M |
| U.S. Federal | $49.1M | $49.8M |
As the company reported it, from the “SEGMENT AND GEOGRAPHIC AREA INFORMATION - Net Revenue From Unaffiliated Customers (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Revenue by segment
- Electronic Test
- Environmental Technologies
- Process Technologies
| Segment | FY2025 | FY2024 |
|---|---|---|
| Electronic Test | $56.2M | $63.9M |
| Environmental Technologies | $29.3M | $28.9M |
| Process Technologies | $28.3M | $37.9M |
As the company reported it, from the “SEGMENT AND GEOGRAPHIC AREA INFORMATION - Segment Reporting Information (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113.8M | $130.7M | $123.3M | $116.8M | $84.9M | $53.8M | $60.7M | $78.6M | $66.8M | $40.2M |
| Cost of revenue | $64.9M | $75.3M | $66.3M | $63.4M | $43.7M | $29.7M | $31.4M | $39.2M | $32.1M | $19.8M |
| Gross profit | $48.9M | $55.4M | $57.0M | $53.4M | $41.2M | $24.1M | $29.2M | $39.4M | $34.7M | $20.4M |
| R&D | $9.4M | $8.5M | $7.6M | $7.5M | $5.5M | $5.1M | $5.0M | $4.9M | $4.3M | $3.7M |
| SG&A | $22.2M | $23.6M | $21.3M | $19.3M | $15.9M | $11.4M | $13.0M | $12.8M | $11.7M | $7.0M |
| Total operating expenses | $52.6M | $52.0M | $46.5M | $42.7M | $32.8M | $25.3M | $26.7M | $34.2M | $31.1M | $16.2M |
| Operating income | -$3.7M | $3.4M | $10.4M | $10.7M | $8.5M | -$1.2M | $2.5M | $5.2M | $3.6M | $4.1M |
| Interest expense | $450.0K | $846.0K | $679.0K | $635.0K | $89.0K | — | — | — | — | — |
| Pre-tax income | -$3.2M | $3.5M | $11.0M | $10.1M | $8.4M | -$1.2M | $2.6M | $5.0M | $3.8M | $4.2M |
| Income tax | $695.0K | $563.0K | $1.7M | $1.7M | $1.1M | $336.0K | $282.0K | $2.0M | $2.9M | $1.5M |
| Net income | -$2.5M | $2.9M | $9.3M | $8.5M | $7.3M | -$895.0K | $2.3M | $3.0M | $975.0K | $2.7M |
| EPS, basic | -0.21 | 0.24 | 0.82 | 0.79 | 0.70 | -0.09 | 0.22 | 0.29 | 0.09 | 0.26 |
| EPS, diluted | -0.21 | 0.24 | 0.79 | 0.78 | 0.68 | -0.09 | 0.22 | 0.29 | 0.09 | 0.26 |
| Shares, diluted (wtd. avg.) | 12.2M | 12.2M | 11.8M | 10.9M | 10.7M | 10.3M | 10.4M | 10.4M | 10.3M | 10.3M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $14.2M | $19.8M | $45.3M | $13.4M | $21.2M | $10.3M | $7.6M | $17.9M | $13.3M | $28.6M |
| Receivables | $25.9M | $29.5M | $18.2M | $21.2M | $16.5M | $8.4M | $9.3M | $10.6M | $12.2M | $5.4M |
| Inventory | $31.6M | $26.8M | $20.1M | $22.6M | $12.9M | $7.5M | $7.2M | $6.5M | $5.0M | $3.7M |
| Total current assets | $78.6M | $78.8M | $85.8M | $60.1M | $52.1M | $27.0M | $24.9M | $35.6M | $31.0M | $38.0M |
| Property, plant and equipment | $4.8M | $4.5M | $3.2M | $3.1M | $2.7M | $2.4M | $2.4M | $2.7M | $1.5M | $944.0K |
| Goodwill | $32.4M | $30.7M | $21.7M | $21.6M | $21.4M | $13.7M | $13.7M | $13.7M | $13.7M | $1.7M |
| Other intangibles | $24.9M | $26.4M | $8.2M | $10.2M | $13.2M | $5.7M | $6.9M | $8.2M | $9.3M | $365.0K |
| Total assets | $151.3M | $152.3M | $134.8M | $110.1M | $103.9M | $62.0M | $59.7M | $67.2M | $62.5M | $42.8M |
| Accounts payable | $11.2M | $8.0M | $5.5M | $7.4M | $4.3M | $2.4M | $2.0M | $1.8M | $2.0M | $1.4M |
| Short-term debt | $6.1M | $7.5M | $4.1M | $4.1M | $4.1M | $0 | — | — | — | — |
| Total current liabilities | $35.8M | $31.9M | $24.3M | $26.9M | $25.1M | $8.9M | $8.4M | $21.4M | $14.4M | $5.1M |
| Long-term debt | $1.4M | $7.5M | $7.9M | $12.0M | $16.0M | $0 | — | — | — | — |
| Total liabilities | $47.7M | $52.5M | $38.5M | $45.1M | $49.1M | $17.3M | $14.9M | $24.3M | $23.2M | $5.1M |
| Retained earnings | $42.6M | $45.1M | $42.2M | $32.9M | $24.4M | $17.1M | $18.0M | $15.7M | $12.6M | $11.7M |
| Total equity | $103.6M | $99.8M | $96.3M | $65.0M | $54.8M | $44.8M | $44.8M | $42.9M | $39.3M | $37.8M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.3M | $3.8M | $16.2M | -$1.4M | $10.8M | $3.2M | -$8.4M | $11.0M | $7.2M | $4.3M |
| Depreciation and amortisation | $6.8M | $5.4M | $4.7M | $4.7M | $3.1M | $3.2M | $3.2M | $1.9M | $1.8M | $599.0K |
| Stock-based compensation | $1.6M | $1.9M | $2.0M | $1.8M | $1.4M | $671.0K | $884.0K | $653.0K | $344.0K | $269.0K |
| Capital expenditure | $1.6M | $1.3M | $1.3M | $1.4M | $994.0K | $658.0K | $620.0K | $2.2M | $745.0K | $339.0K |
| Investing cash flow | -$1.6M | -$20.1M | -$1.3M | -$1.2M | -$21.4M | -$648.0K | -$620.0K | -$6.3M | -$22.7M | -$339.0K |
| Financing cash flow | -$8.2M | -$8.6M | $15.6M | -$3.7M | $21.7M | -$74.0K | -$1.1M | — | -$62.0K | -$978.0K |
| Buybacks | $0 | $1.0M | $0 | — | $0 | $74.0K | $1.1M | — | $62.0K | $978.0K |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001036262-26-000024.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.2M | $66.8M | $78.6M | $60.7M | $53.8M | $84.9M | $116.8M | $123.3M | $130.7M | $113.8M |
| Gross profit | $20.4M | $34.7M | $39.4M | $29.2M | $24.1M | $41.2M | $53.4M | $57.0M | $55.4M | $48.9M |
| Net income | $2.7M | $975.0K | $3.0M | $2.3M | -$895.0K | $7.3M | $8.5M | $9.3M | $2.9M | -$2.5M |
Recent filings and events
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Results announced Item 2.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Material agreement signed Item 1.01
- Results announced Item 2.02
- New debt or obligation Item 2.03
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Officer or director change Item 5.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 3825
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| TER | TERADYNE, INC | $48.29B | 89.0x | 13.1% |
| VLTO | Veralto Corp | $25.62B | 27.7x | 6.0% |
| ITRI | ITRON, INC. | $3.84B | 13.5x | -3.0% |
| COHU | COHU INC | $2.27B | — | 12.7% |
| AEHR | AEHR TEST SYSTEMS | $1.80B | — | -15.2% |
| ALNT | ALLIENT INC | $1.49B | 66.4x | 4.6% |
| TRNS | TRANSCAT INC | $766.8M | 143.7x | 19.2% |
| DAIO | DATA I/O CORP | $25.6M | — | -1.2% |